TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9863162

Group type: EXPERIMENTAL
Intervention: Low dose (LD) of β‐carboxyethylgermanium sesquioxide (Ge‐132) 1 g · m‐2
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Medium dose (MD) of β‐carboxyethylgermanium sesquioxide (Ge‐132) 2.5 g · m‐2
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High dose (HD) of β‐carboxyethylgermanium sesquioxide (Ge‐132) 4 g · m‐2
Number of subjects: 24
Study: 2000792

Group type: EXPERIMENTAL
Intervention: Guanadrel sulfate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 15
Study: 6340909

Group type: EXPERIMENTAL
Intervention: 60 mg extended-release fenfluramine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 31992327

Group type: EXPERIMENTAL
Intervention: 49Gy/7f (BED10: 83.3Gy)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 54Gy/6f (BED10: 102.6Gy)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 55Gy/5f (BED10: 115.5Gy)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 3
Study: 31743103

Group type: EXPERIMENTAL
Intervention: Child-parent relationship therapy (CPRT) in 10 sessions for 45-60 minutes each
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine preschool education
Number of subjects: 60
Study: 28440045

Group type: COMPARATOR
Intervention: Lorcaserin 10 mg BID
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg BID + Phentermine 15 mg QD
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg BID + Phentermine 15 mg BID
Number of subjects: 238
Study: 26137952

Group type: EXPERIMENTAL
Intervention: Hypertension (self-report of current drug therapy for hypertension)
Number of subjects: 6426

Group type: EXPERIMENTAL
Intervention: Antihypertensive medication with BP ≥140/90 mm Hg (uncontrolled BP)
Number of subjects: 6426

Group type: COMPARATOR
Intervention: Sodium intake >1,500 mg/day
Number of subjects: 6426
Study: 24846935

Group type: EXPERIMENTAL
Intervention: Beta-lactam monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-lactam and macrolide combination therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoroquinolone monotherapy
Number of subjects: 0
Study: 23004227

Group type: EXPERIMENTAL
Intervention: Plastic clips (Clip)
Number of subjects: 48
Study: 19885777

Group type: EXPERIMENTAL
Intervention: Whole body vibration
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 10
Study: 17230616

Group type: EXPERIMENTAL
Intervention: Pronase premedication
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) premedication
Number of subjects: 146

Group type: COMPARATOR
Intervention: Gascon
Number of subjects: 146

Group type: COMPARATOR
Intervention: Gascon water
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: CLO test sensitivity and specificity
Number of subjects: 146
Study: 15339895

Group type: EXPERIMENTAL
Intervention: Educational epidemiology approaches (observational designs and randomized experimental designs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comprehensive national network of educational epidemiologists
Number of subjects: 0
Study: 12549708

Group type: EXPERIMENTAL
Intervention: Preschooler-parent psychotherapy (PPP, n = 23)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Psychoeducational home visitation (PHV, n = 34)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Community standard (CS, n = 30)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Nonmaltreating comparison group (NC, n = 35)
Number of subjects: 122
Study: 9643060

Group type: EXPERIMENTAL
Intervention: Task-relevant stimuli (auditory and visual)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Task-irrelevant stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditioned stimuli (CSs) in differential conditioning with an aversive unconditioned stimulus (US)
Number of subjects: 0
Study: 7862273

Group type: EXPERIMENTAL
Intervention: CT angiography (CTA) using 60 cc of contrast (medium 2 cc/sec) with 5 mm slices, reconstructed at 3 mm slice thickness (Group 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CT angiography (CTA) using 90 cc of contrast (medium 3 cc/sec) with 3 mm slices, reconstructed at 1 mm slice thickness (Group 2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional angiography (control)
Number of subjects: 20
Study: 2675587

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 30, 60 or 90 mg administered once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31749143

Group type: EXPERIMENTAL
Intervention: Frequent screening (ages 22/25/28; Arm 1: 2,073 females)
Number of subjects: 4273

Group type: EXPERIMENTAL
Intervention: Infrequent screening (age 28; Arm 2: 2,200 females)
Number of subjects: 4273

Group type: EXPERIMENTAL
Intervention: Safety Arm (females vaccinated at age 18; Arm 3: 1,329 females)
Number of subjects: 4273
Study: 30478375

Group type: EXPERIMENTAL
Intervention: Entropy descriptor method for predicting synthesizability of high-entropy materials.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-entropy homogeneous phases.
Number of subjects: 0
Study: 28421240

Group type: EXPERIMENTAL
Intervention: Rhenium-188-HEDP combined with docetaxel and prednisone
Number of subjects: 88

Group type: COMPARATOR
Intervention: Docetaxel and prednisone alone
Number of subjects: 88
Study: 26136593

Group type: EXPERIMENTAL
Intervention: Normal Polyphenol Concentration in Orange Juice (NPJ)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High Polyphenol Concentration in Orange Juice (HPJ)
Number of subjects: 100
Study: 24016497

Group type: EXPERIMENTAL
Intervention: Optimal medical therapy (OMT)
Number of subjects: 2275

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 2275

Group type: EXPERIMENTAL
Intervention: Number of vessels diseased (VD)
Number of subjects: 2275
Study: 20978715

Group type: EXPERIMENTAL
Intervention: Aggrenox
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 18302858

Group type: EXPERIMENTAL
Intervention: Basic component of the new WHO antenatal care model
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Increasing parity
Number of subjects: 1022
Study: 16301945

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle strengthening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises
Number of subjects: 0
Study: 11834646

Group type: EXPERIMENTAL
Intervention: Discontinuation of furosemide
Number of subjects: 20
Study: 10479834

Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inhalatory anaesthesia
Number of subjects: 50
Study: 7618675

Group type: EXPERIMENTAL
Intervention: Dorsalis pedis artery measurement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radial artery measurement
Number of subjects: 0
Study: 2201660

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6127435

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 0
Study: 30792037

Group type: EXPERIMENTAL
Intervention: Nystatin-neomycin-polymyxin B combination (NNP) for 12 days
Number of subjects: 611

Group type: COMPARATOR
Intervention: Miconazole for 3 days followed by 9 days of placebo
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Nystatin-neomycin-polymyxin B combination (NNP)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Miconazole
Number of subjects: 611
Study: 28710596

Group type: EXPERIMENTAL
Intervention: e‐cigarette use
Number of subjects: 788
Study: 26062622

Group type: EXPERIMENTAL
Intervention: PEG and enteral nutrition
Number of subjects: 726

Group type: COMPARATOR
Intervention: Nutritional counselling (non-PEG group)
Number of subjects: 726
Study: 23617696

Group type: EXPERIMENTAL
Intervention: Conquer Fear Intervention
Number of subjects: 260

Group type: COMPARATOR
Intervention: Relaxation training
Number of subjects: 260
Study: 21542956

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (30 mg/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 50
Study: 19473613

Group type: EXPERIMENTAL
Intervention: Resistance training (n = 19)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low-intensity aerobic training (n = 8)
Number of subjects: 27
Study: 17308528

Group type: EXPERIMENTAL
Intervention: TEA+GA
Number of subjects: 80

Group type: COMPARATOR
Intervention: GA
Number of subjects: 80
Study: 15179180

Group type: EXPERIMENTAL
Intervention: Modafinil (4 mg x kg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study: 12562588

Group type: EXPERIMENTAL
Intervention: Prazosin (mean dose=9.5 mg/day at bedtime, SD=0.5)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9649988

Group type: EXPERIMENTAL
Intervention: PCA group received a continuous infusion of 1.5 mg h‐1 piritramide
Number of subjects: 20

Group type: COMPARATOR
Intervention: i.m. group received 0.3 mg kg‐1 piritramide i.m. when requested by the patient
Number of subjects: 20
Study: 7588182

Group type: EXPERIMENTAL
Intervention: Antidepressants (imipramine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3338367

Group type: EXPERIMENTAL
Intervention: Golytely supplemented with simethicone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Golytely alone
Number of subjects: 0
Study: 31553463

Group type: EXPERIMENTAL
Intervention: Laparoscopy-Assisted Distal Gastrectomy (LADG) with D2 lymphadenectomy
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Laparoscopy-Assisted Distal Gastrectomy (LADG)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Open Distal Gastrectomy (ODG) with D2 lymphadenectomy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Open Distal Gastrectomy (ODG)
Number of subjects: 96
Study: 28434056

Group type: COMPARATOR
Intervention: Behavioral intervention targeting maternal alcohol use, malnutrition, and HIV, specific dosage and duration not available
Number of subjects: 0
Study: 21878465

Group type: EXPERIMENTAL
Intervention: Office ergonomic training
Number of subjects: 6

Group type: COMPARATOR
Intervention: Leaflet (Control)
Number of subjects: 6
Study: 22562070

Group type: EXPERIMENTAL
Intervention: Conventional first aid training plus supplementary training to reduce barriers to helping
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional first aid training (control group)
Number of subjects: 72
Study: 21620064

Group type: EXPERIMENTAL
Intervention: Contemporaneous portal and hepatic artery revascularization (CPAr)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sequential portal and arterial revascularization (SPAr)
Number of subjects: 40
Study: 19336538

Group type: EXPERIMENTAL
Intervention: Sufentanil with sevoflurane end‐tidal concentration of 2.5%
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Sufentanil with sevoflurane end‐tidal concentration of 3%
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Sufentanil with sevoflurane end‐tidal concentration of 3.5%
Number of subjects: 63
Study: 17059015

Group type: EXPERIMENTAL
Intervention: Four-step therapeutics of Traditional Chinese Medicine (TCM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 100mg Lamivudine orally daily for two years (Control)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Four-step therapeutics of TCM
Number of subjects: 120
Study: 15546231

Group type: EXPERIMENTAL
Intervention: Distraction during recovery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Hostility
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no distraction)
Number of subjects: 80
Study: 10908991

Group type: EXPERIMENTAL
Intervention: Active treatment with Meniett apparatus
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 56
Study: 9077718

Group type: EXPERIMENTAL
Intervention: 15 mg lansoprazole
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole
Number of subjects: 17
Study: 8113660

Group type: EXPERIMENTAL
Intervention: 1.5 mg of prostaglandin E2 in 3 ml of gel intracervically
Number of subjects: 48

Group type: COMPARATOR
Intervention: 3 mg prostaglandin E2 tablet intravaginally
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intracervical route
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intravaginal route
Number of subjects: 48
Study: 3295034

Group type: EXPERIMENTAL
Intervention: slow-potassium (72 mmol/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: slow-sodium (90 mmol/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: low sodium/high potassium diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: sodium restriction alone
Number of subjects: 40
Study: 31618456

Group type: EXPERIMENTAL
Intervention: Reduced-dose plerixafor (0.12 mg/kg) plus filgrastim (10 μg/kg/4 days)
Number of subjects: 20
Study: 27989565

Group type: EXPERIMENTAL
Intervention: Wearable technology to track bite portions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mental tracking of food intake
Number of subjects: 0
Study: 26572609

Group type: EXPERIMENTAL
Intervention: Protein-rich nutritional supplementation (40g of protein and 600 kcal daily for six months) and bisphosphonates (once weekly for 12 months)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Bisphosphonates alone (once weekly for 12 months)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Calcium (1g daily) and vitamin D3 (800 IU daily)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (Protein-rich)
Number of subjects: 79
Study: 23546559

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2O) by inhalation
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Deep sedation (intravenous mixture of midazolam, remifentanil, and propofol)
Number of subjects: 450

Group type: COMPARATOR
Intervention: No sedation
Number of subjects: 450
Study: 21334008

Group type: EXPERIMENTAL
Intervention: Internal thoracic artery grafting
Number of subjects: 3087
Study: 19630726

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nalmefene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naltrexone depot
Number of subjects: 0
Study: 20143498

Group type: EXPERIMENTAL
Intervention: Caucasian/European Americans
Number of subjects: 2221

Group type: EXPERIMENTAL
Intervention: Black/African‐Americans
Number of subjects: 2221

Group type: EXPERIMENTAL
Intervention: Hispanic/Latino‐Americans
Number of subjects: 2221

Group type: EXPERIMENTAL
Intervention: Asian‐Americans
Number of subjects: 2221

Group type: EXPERIMENTAL
Intervention: Others
Number of subjects: 2221

Group type: EXPERIMENTAL
Intervention: Unknown
Number of subjects: 2221
Study: 15679750

Group type: EXPERIMENTAL
Intervention: Rapid detoxification with general anaesthesia (RD-GA)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Rapid detoxification without general anaesthesia (RD)
Number of subjects: 272
Study: 12168912

Group type: EXPERIMENTAL
Intervention: Taxotere plus bromocriptine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Taxotere alone
Number of subjects: 30
Study: 9722274

Group type: EXPERIMENTAL
Intervention: Amorphous calcium phosphate
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (water solution)
Number of subjects: 38
Study: 7989852

Group type: EXPERIMENTAL
Intervention: Homework policy instituted
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Modifications for students with disabilities
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Frequency and amount of homework assigned
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Home-school communication mechanisms
Number of subjects: 550
Study: 2730998

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (300 mg/kg body weight)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (8 g sodium chloride)
Number of subjects: 23
Study: 1101842

Group type: EXPERIMENTAL
Intervention: Very high dose fluphenazine (1,200 mg/day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard dose fluphenazine
Number of subjects: 31
Study: 31951771

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E
Number of subjects: 100

Group type: COMPARATOR
Intervention: HepB control vaccine
Number of subjects: 100
Study: 31849356

Group type: EXPERIMENTAL
Intervention: Single-layer continuous sutures (group I)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Two-layer interrupted sutures (group II)
Number of subjects: 103
Study: 30013091

Group type: EXPERIMENTAL
Intervention: Panitumumab
Number of subjects: 559

Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 559
Study: 29798042

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Traditional separation surgery
Number of subjects: 68
Study: 24697345

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment combined with bladder training (n = 440)
Number of subjects: 845

Group type: COMPARATOR
Intervention: Pharmacological treatment alone (n = 405)
Number of subjects: 845
Study: 21843001

Group type: EXPERIMENTAL
Intervention: HIV risk-reduction intervention
Number of subjects: 715
Study: 19887347

Group type: EXPERIMENTAL
Intervention: Kefir
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 17178774

Group type: EXPERIMENTAL
Intervention: Eccentric exercises with a night splint (night splint group, n = 36)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Eccentric exercises only (eccentric group, n = 34)
Number of subjects: 70
Study: 14970839

Group type: EXPERIMENTAL
Intervention: Alcoholic red wine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dealcoholized red wine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water
Number of subjects: 8
Study: 11567937

Group type: EXPERIMENTAL
Intervention: Solar disinfection of drinking water
Number of subjects: 299

Group type: COMPARATOR
Intervention: Control (water kept indoors)
Number of subjects: 299
Study: 9543139

Group type: EXPERIMENTAL
Intervention: Hormonal contraception
Number of subjects: 19

Group type: COMPARATOR
Intervention: Regular menstrual cycle
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 8059074

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study: 3195646

Group type: EXPERIMENTAL
Intervention: Intraoperative perfluorocarbon liquids
Number of subjects: 23
Study: 29354930

Group type: EXPERIMENTAL
Intervention: Skin needle embedding therapy
Number of subjects: 300
Study: 27631719

Group type: EXPERIMENTAL
Intervention: Usual care plus dietitian-delivered DASH-based dietary counselling in a single one-to-one session (n=281)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Standard education (usual care) (n=275)
Number of subjects: 556
Study: 26586732

Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg every 2 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 23444204

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open flap debridement
Number of subjects: 40
Study: 19880189

Group type: EXPERIMENTAL
Intervention: Imipramine, venlafaxine, or venlafaxine plus quetiapine during follow-up
Number of subjects: 59
Study: 18928105

Group type: EXPERIMENTAL
Intervention: Sanhuang Yilong Decoction (SYD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-steroid anti-inflammatory drugs
Number of subjects: 90
Study: 17064543

Group type: EXPERIMENTAL
Intervention: Lumbar surgery for patients with degenerative knee joints
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Lumbar surgery for patients with degenerative hip joints
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group (160 patients with lower extremity joint pain and negative physical examination)
Number of subjects: 237
Study: 12373475

Group type: EXPERIMENTAL
Intervention: Early surfactant administration (Curosurf at a dose of 100 mg/kg as a single bolus via the endotracheal tube within 1 min after intubation)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Early surfactant administration
Number of subjects: 43

Group type: COMPARATOR
Intervention: Delayed surfactant administration (during HFOV only when defined criteria were reached)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Delayed surfactant administration
Number of subjects: 43
Study: 10407204

Group type: EXPERIMENTAL
Intervention: Incongruent trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Congruent, neutral, or word identification trials
Number of subjects: 0
Study: 7760659

Group type: EXPERIMENTAL
Intervention: Cortisporin Otic Suspension (COS; 0.5 mL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (untreated ear)
Number of subjects: 50
Study: 2081608

Group type: EXPERIMENTAL
Intervention: Propranolol (80-160 mg per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Acebutolol (400-800 mg per day)
Number of subjects: 30
Study: 115039

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 29461121

Group type: EXPERIMENTAL
Intervention: Topical 3% tranexamic acid combined with 1064-nm QSNYL laser
Number of subjects: 25

Group type: COMPARATOR
Intervention: Vehicle treatment (control)
Number of subjects: 25
Study: 26514079

Group type: EXPERIMENTAL
Intervention: ICT-guided-DMS
Number of subjects: 179

Group type: COMPARATOR
Intervention: ICT-guided-DMS + telemonitoring
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 179
Study: 25123170

Group type: EXPERIMENTAL
Intervention: Three daily servings of dairy products
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control products equivalent in macronutrients and sodium
Number of subjects: 89
Study: 23505165

Group type: EXPERIMENTAL
Intervention: Facebook Plus text messaging and personalized feedback
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Facebook
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waiting List control
Number of subjects: 52
Study: 20500135

Group type: EXPERIMENTAL
Intervention: Conical-PEP breathing with a positive expiratory pressure of 4-20 cmH2O during exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normal breathing
Number of subjects: 13